NCT04433767View on ClinicalTrials.gov

Depressed Mood Improvement Through Nicotine Dosing 2

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions
Depressive Disorder
Interventions
DRUG

Transdermal Nicotine patch

"Participants will begin a 12- week open label trial of transdermal nicotine patch during the day and remove it at night (16 hours). Dose titration starting at 3.5 mg patch/daily to maximum of 21mg patch/daily.~After week 12 , dose will be slowly tapered over 3 weeks."

Trial Locations (1)

37212

Vanderbilt Psychiatric Hospital, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04433767 - Depressed Mood Improvement Through Nicotine Dosing 2 | Biotech Hunter | Biotech Hunter